Friends & Family

You want to help. But you may not know what you can do for a friend or family member with sickle cell disease.

The good news is that, just by knowing some basic facts, you can help protect your loved one against misunderstanding.

Myths and Facts

Take a moment to learn some common myths and facts about sickle cell disease.

Myth

You can catch sickle cell disease from another person.

Fact

Sickle cell disease is hereditary, not contagious. That means you can't catch it. The only way you can get sickle cell disease is from your parents, before you were born. You either inherited the genes for sickle cell disease or you didn't. Nothing you do can change that fact.

Myth

People who have the sickle cell trait can develop sickle cell disease.

Fact

You cannot get sickle cell disease just from having the trait. Having the sickle cell trait only means that there is a chance your children may have sickle cell disease if you have children with someone else who has the trait.

Myth

Sickle cell disease only affects African-Americans.

Fact

Sickle cell disease is more common among people of African or Hispanic descent. But it is found among people of all ancestries.

Myth

The treatment of sickle cell disease never really improves. Nobody cares about changing this condition.

Fact

In the past 30 years, many advances have been made in the treatment of sickle cell disease. Early detection through screening of newborns improves survival.1 Bone marrow transplants can cure some children with sickle cell disease if they have a matched donor.2

Myth

People with sickle cell disease die at a young age.

Fact

Many people with sickle cell disease have a normal lifespan. The key to living a long life with sickle cell disease is to get good medical care and keep a positive outlook.

Myth

There's nothing you can do to help.

Fact

Helping is something you do just by caring. You don't need to take on a lot of responsibility. Among the many small and important things you can do, one is just learning more about the condition. Know the difference between myth and reality. Making the effort to understand what it is like for the person you care about is a great way to help. It may help you feel better as well.

Learn More*

There are many websites where you can learn more about sickle cell disease and read stories of people who live with it. You may want to visit:

  • The Sickle Cell Disease Association of America (SCDAA)
    sicklecelldisease.org
    Another source for education about sickle cell disease.
  • American Sickle Cell Anemia Association (ASCAA)
    ascaa.org
    Find education about sickle cell disease.
  • Net of Care
    NetofCare.org
    Information and resources for caregivers to people with sickle cell disease.
  • Sickle Cell Advocates for Research and Empowerment (SCARE)
    defiers.com
    Find songs, stories, and poetry by people with sickle cell disease.
  • SickleCellKids.org
    SickleCellKids.org
    A fun, educational site for kids. Requires Adobe Flash®.

* The websites listed on this page are maintained by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy, completeness, adequacy, or any other aspect of the information contained on such sites.

Pass It On

Understanding is important. For someone living with sickle cell disease, the more their friends and family understand about the disease, the better. If you know someone who might like to learn more, you may print this page or send it by email.


Read patient experiences of those taking EXJADE


Reference
  1. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023-7.
  2. Onitilo AA, Lazarchick J, Brunson CY, Frei-Lahr D, Stuart RK. Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc. 2003;35(8):3089-92.
Print page
Email page
Learn About EXJADE

EXJADE is the once-daily oral treatment for chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.

Further studies are being performed to determine the long-term benefits and risks of EXJADE.

Learn more
In Their Own Words

Read what others are saying about EXJADE.

Learn More

EXJADE is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years and older.

Further studies are being performed to determine the long-term benefits and risks of EXJADE.

Important safety information about EXJADE

People who are allergic to EXJADE or any ingredient of EXJADE should not take EXJADE.

Before you start EXJADE, your doctor will give you blood tests, because EXJADE may affect your kidneys, liver, or blood. The blood tests will be performed every month to check your kidney and liver function, your serum ferritin levels, and your blood count. If you are at increased risk of complications because you have a pre-existing kidney condition, are elderly, have multiple medical conditions, or are taking medicine that affects your kidneys, your doctor will give you a blood test every week for the first month you are taking EXJADE or if your dose has changed, and then every month after that. Your doctor may also collect urine samples monthly.

Some patients developed severe kidney problems, in some cases fatal, while on EXJADE. Most of the fatalities occurred in patients who were very ill because of their disease. There may be increased risk of complications for patients who already have a kidney condition, are elderly, have multiple medical conditions, or take medicine that affects kidney function.

Some patients developed severe liver problems, in some cases fatal, while on EXJADE. Many of these patients were greater than 55 years of age and/or had multiple medical conditions already affecting their liver.

Some patients developed blood disorders, in some cases fatal, while on EXJADE therapy, but it is not known whether this was a result of EXJADE therapy or other causes, as most of these patients already had diseases affecting their blood.

Serious allergic reactions (which include swelling of the throat) have been reported in patients taking EXJADE, usually within the first month of treatment. If reactions are severe, stop taking EXJADE and contact your doctor immediately.

You may also receive a hearing or vision test prior to receiving EXJADE and yearly thereafter. Your dose of EXJADE may be changed if needed based on the results of these tests.

Should you develop swelling of the throat, a severe rash, or any hearing problems or vision disturbances, please contact your doctor.

EXJADE should be taken once daily on an empty stomach, at least 30 minutes prior to food, preferably at the same time every day.

EXJADE should not be chewed or swallowed whole, and should not be taken at the same time as aluminum-containing antacids (for example, Maalox®).

The most commonly reported side effects related to EXJADE in clinical trials were mainly nausea, vomiting, diarrhea, stomach pain, fever, cough, headache, increases in kidney lab values, and skin rash. These side effects were mild to moderate in severity. If you experience diarrhea or vomiting you should ensure that you continue to drink fluids.

Please see the full prescribing information.

*Maalox® is a registered trademark of Novartis Consumer Health, Inc.